ID   Luc63.2.22
AC   CVCL_UW14
SY   Luc63; MuLuc63
DR   Wikidata; Q95983312
RX   Patent=US8461306;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5950.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare the humanized elotuzumab (HuLuc63; Empliciti) therapeutic antibody. It was developed for the treatment of multiple myeloma.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9NQ25; Human SLAMF7/CD319.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
RX   Patent=US8461306;
RA   Williams M., Tso J.Y., Landolfi N.F., Powers D.B., Liu G.;
RT   "Therapeutic use of anti-CS1 antibodies.";
RL   Patent number US8461306, 11-Jun-2013.
//